메뉴 건너뛰기




Volumn 11, Issue 5, 1997, Pages 929-933

The management of failed dual or triple therapy for Helicobacter pylori eradication

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE; TETRACYCLINE;

EID: 0030798393     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00228.x     Document Type: Article
Times cited : (32)

References (28)
  • 1
    • 0026486714 scopus 로고
    • Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori
    • Chiba N, Rao BV, Radamaker JVV, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992; 87: 1716-27.
    • (1992) Am J Gastroenterol , vol.87 , pp. 1716-1727
    • Chiba, N.1    Rao, B.V.2    Radamaker, J.V.V.3    Hunt, R.H.4
  • 2
    • 0028001018 scopus 로고
    • Helicobacter pylori eradication: Understandable caution but no excuse for exertion
    • Penston JG. Helicobacter pylori eradication: understandable caution but no excuse for exertion. Aliment Pharmacol Ther 1994: 8: 369-89.
    • (1994) Aliment Pharmacol Ther , vol.8 , pp. 369-389
    • Penston, J.G.1
  • 3
    • 0028022510 scopus 로고
    • Zagari RM, Fossi S, et al Short-term low-dose triple therapy for eradication of Helicobacter pylori
    • Bazzoli F. Zagari RM, Fossi S, et al Short-term low-dose triple therapy for eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994: 6: 773-7.
    • (1994) Eur J Gastroenterol Hepatol , vol.6 , pp. 773-777
    • Bazzoli, F.1
  • 4
    • 0029562077 scopus 로고
    • One week treatment for Helicobacter pylori infection: A randomised study of quadruple therapy versus triple therapy
    • PhuIl PS, Griffiths AE, Halliday D, Jacyna MR. One week treatment for Helicobacter pylori infection: a randomised study of quadruple therapy versus triple therapy. J Antimicrob Chem 1995: 36: 1085-8.
    • (1995) J Antimicrob Chem , vol.36 , pp. 1085-1088
    • Phuil, P.S.1    Griffiths, A.E.2    Halliday, D.3    Jacyna, M.R.4
  • 5
    • 0029142883 scopus 로고
    • Omeprazole-based . antimicrobial therapies: Results in 198 Helicobacter pylori-positive patients
    • Deltenre M, Jonas C, van Gossum M, et al. Omeprazole-based . antimicrobial therapies: results in 198 Helicobacter pylori-positive patients. Eur J Gastroenterol Hepatol 1995; 7(Suppl. 1): 39-44.
    • (1995) Eur J Gastroenterol Hepatol , vol.7 , Issue.SUPPL. 1 , pp. 39-44
    • Deltenre, M.1    Jonas, C.2    Van Gossum, M.3
  • 7
    • 0028339653 scopus 로고
    • Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease
    • Labenz J, Ruhl GH, Bertrams J, Borsch G. Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease. Aliment Pharmacol Ther 1994; 8: 323-7.
    • (1994) Aliment Pharmacol Ther , vol.8 , pp. 323-327
    • Labenz, J.1    Ruhl, G.H.2    Bertrams, J.3    Borsch, G.4
  • 8
    • 0027447246 scopus 로고
    • Failure to eradicate Helicobacter pylori in patients with metronidazole-resistant strains
    • Zwet AA, Thijs JC, Oom JAJ, Hoogeveen K. Failure to eradicate Helicobacter pylori in patients with metronidazole-resistant strains. Eur J Gastroenterol Hepatol 1993; 5: 185-6.
    • (1993) Eur J Gastroenterol Hepatol , vol.5 , pp. 185-186
    • Zwet, A.A.1    Thijs, J.C.2    Oom, J.A.J.3    Hoogeveen, K.4
  • 9
    • 0026575078 scopus 로고
    • Role of metronidazole resistance
    • Rautelin H, Seppala K, Renkonen 0V. Role of metronidazole resistance. Antimicrob Chemother 1992; 36: 163-6.
    • (1992) Antimicrob Chemother , vol.36 , pp. 163-166
    • Rautelin, H.1    Seppala, K.2
  • 10
    • 3643084607 scopus 로고
    • 95% metronidazole resistance in H. pylori infection in a UK Asian community
    • Abstract.
    • Banatvala N, Davies GR, Abdi Y, Rampton DS, Feldman R. 95% metronidazole resistance in H. pylori infection in a UK Asian community. Gastroenterology 1993; 104: 37(Abstract).
    • (1993) Gastroenterology , vol.104 , pp. 37
    • Banatvala, N.1    Davies, G.R.2    Abdi, Y.3    Rampton, D.S.4    Feldman, R.5
  • 12
    • 0003020590 scopus 로고
    • Primary resistance of Helicobacter pylori strains to metronidazole and to clarithromycin in France in 1993
    • Abstract.
    • Cayala R, Lamouliatte, Mégraud F, Quinton A. Primary resistance of Helicobacter pylori strains to metronidazole and to clarithromycin in France in 1993. Gastroenterology 1994; 106(Suppl. 4): 61(Abstract).
    • (1994) Gastroenterology , vol.106 , Issue.SUPPL. 4 , pp. 61
    • Cayala, R.1    Lamouliatte2    Mégraud, F.3    Quinton, A.4
  • 13
    • 0001406542 scopus 로고
    • Clarithromycin resistance of Helicobacter pylori strains before and after treatment: A key factor of treatment failures
    • Abstract.
    • Cayala R, Zerbib F, Mégraud F, Lamouliatte H. Clarithromycin resistance of Helicobacter pylori strains before and after treatment: a key factor of treatment failures. Gastroenterology 1995; 108: 68(Abstract).
    • (1995) Gastroenterology , vol.108 , pp. 68
    • Cayala, R.1    Zerbib, F.2    Mégraud, F.3    Lamouliatte, H.4
  • 14
    • 0028288729 scopus 로고
    • Eradication of Helicobacter pylori with clarithromycin and omeprazole
    • Logan RPH, Gummett PA, Shaufelberger HD, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994; 35: 323-6.
    • (1994) Gut , vol.35 , pp. 323-326
    • Logan, R.P.H.1    Gummett, P.A.2    Shaufelberger, H.D.3
  • 15
    • 0029091042 scopus 로고
    • Efficacy and optimum dosage of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori
    • Moayyedi P, Sahay P, Tompkins D, Axon ATR. Efficacy and optimum dosage of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. EUT }Gastroenterol Hepatol 1995; 7: 835-40.
    • (1995) EUT }Gastroenterol Hepatol , vol.7 , pp. 835-840
    • Moayyedi, P.1    Sahay, P.2    Tompkins, D.3    Axon, A.T.R.4
  • 16
    • 0027358581 scopus 로고
    • Clarithromycin as monotherapy for eradication of Helicobacter pylori: A randomized double blind trial
    • Peterson WL, Graham DY, Marshall B, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized double blind trial. Am J Gastroenterol 1993; 88: 1860-4.
    • (1993) Am J Gastroenterol , vol.88 , pp. 1860-1864
    • Peterson, W.L.1    Graham, D.Y.2    Marshall, B.3
  • 18
    • 33847439288 scopus 로고
    • Comparison of two low dose one-week triple therapy regimens with and without metronidazole for cure ofH. pylori infection
    • Abstract.
    • Jaup BH, Norrby A. Comparison of two low dose one-week triple therapy regimens with and without metronidazole for cure ofH. pylori infection. San Diego: DDW, 14-17 May 1995, 212 7( Abstract).
    • (1995) San Diego: DDW, 14-17 May , vol.212 , pp. 7
    • Jaup, B.H.1    Norrby, A.2
  • 19
    • 0028074524 scopus 로고
    • Clarithromycin, tetracycline, and bismuth: A new non-metronidazole therapy for Helicobacter pylori infection
    • Al-Assi MT, Ramirez FC, Lew GM, Genta RM, Graham DY. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. Am J Gastroenterol 1994; 89: 1203-5.
    • (1994) Am J Gastroenterol , vol.89 , pp. 1203-1205
    • Al-Assi, M.T.1    Ramirez, F.C.2    Lew, G.M.3    Genta, R.M.4    Graham, D.Y.5
  • 20
    • 0029912572 scopus 로고    scopus 로고
    • Dual therapy versus triple therapy for Helicobacter pi//ori-associated duodenal ulcers
    • Sung JJY, Chung S, Ling TKW, et al. Dual therapy versus triple therapy for Helicobacter pi//ori-associated duodenal ulcers. Dig Dis Sei 1996; 3: 453-7.
    • (1996) Dig Dis Sei , vol.3 , pp. 453-457
    • Sung, J.J.Y.1    Chung, S.2    Ling, T.K.W.3
  • 21
    • 33847436804 scopus 로고    scopus 로고
    • Use Clo-test to predict the success of omeprazole/amoxicillin for cure of Helicobacter pylori infection
    • Abstract.
    • Chen CY, Chen CY, Chan TT, Lin XZ. Use Clo-test to predict the success of omeprazole/amoxicillin for cure of Helicobacter pylori infection. San Francisco: DDW, 19-22 May 1996, 3907(Abstract).
    • (1996) San Francisco: DDW, 19-22 May , vol.3907
    • Chen, C.Y.1    Chen, C.Y.2    Chan, T.T.3    Lin, X.Z.4
  • 23
    • 0029949471 scopus 로고    scopus 로고
    • Choosing the best antiHelicobacter pylori therapy: Effect of antimicrobial resistance
    • Graham DY, de Boer WA, Tytgat GNJ. Choosing the best antiHelicobacter pylori therapy: effect of antimicrobial resistance. Am] Gastroenterol 1996; 91: 1072-6.
    • (1996) Am Gastroenterol , vol.91 , pp. 1072-1076
    • Graham, D.Y.1    De Boer, W.A.2    Tytgat, G.N.J.3
  • 25
    • 0029569054 scopus 로고
    • Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: Results of a randomized prospective single-centre study
    • de Boer WA, Driessen WMM, Jansz AR, Tytgat GNJ. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study. Eur J Gastroenterol Hepatol 1995; 7: 1189-94.
    • (1995) Eur J Gastroenterol Hepatol , vol.7 , pp. 1189-1194
    • Boer, W.A.1    Driessen, W.M.M.2    Jansz, A.R.3    Tytgat, G.N.J.4
  • 26
    • 0024158757 scopus 로고
    • Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones
    • Hardy DJ, Hanson CW, Hensey DM, et al. Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones. J Antimicrob Chemother 1988: 22: 631-6.
    • (1988) J Antimicrob Chemother , vol.22 , pp. 631-636
    • Hardy, D.J.1    Hanson, C.W.2    Hensey, D.M.3
  • 27
    • 0030068225 scopus 로고    scopus 로고
    • Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori
    • Verslovic J, Shortridge D, Kibsten K, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996; 40: 477-80.
    • (1996) Antimicrob Agents Chemother , vol.40 , pp. 477-480
    • Verslovic, J.1    Shortridge, D.2    Kibsten, K.3
  • 28
    • 4243822859 scopus 로고    scopus 로고
    • Optimal compliance eliminates differences in eradication rates between 2-week dual and 1-week triple therapy for Helicobacter pylori gastritis
    • Abstract.
    • Erdag S, Boiko JB, Burlage M, et al. Optimal compliance eliminates differences in eradication rates between 2-week dual and 1-week triple therapy for Helicobacter pylori gastritis. Gastroenterology 1996; 110(Suppl. 1): 103(Abstract).
    • (1996) Gastroenterology , vol.110 , Issue.SUPPL. 1 , pp. 103
    • Erdag, S.1    Boiko, J.B.2    Burlage, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.